Navigation Links
Tongjitang Chinese Medicines Company Reports Second Quarter 2010 Financial Results
Date:8/18/2010

class="xn-money">RMB137.9 million ($20.3 million) from RMB134.1 million in the second quarter of 2009. Xianling Gubao ("XLGB") sales were RMB74.1 million ($10.9 million) in the second quarter of 2010, compared to RMB80.7 million in the second quarter of 2009. Net revenue from Moisturizing & Anti-itching Capsules and Zaoren Anshen Capsules reached RMB19.0 million ($2.8 million) in the second quarter of 2010, compared to RMB18.2 million in the second quarter of 2009. Net revenue from the Company's other products increased 27% to RMB44.8 million ($6.6 million) from RMB35.2 million in the second quarter of 2009, including the contribution of approximately RMB2.1 million from the Company's liquor business.

Gross profit decreased 3.1% to RMB 79.2 million ($11.7 million) in the second quarter of 2010 from RMB 81.7 million in the second quarter of 2009. Gross margin was 57.5% in the second quarter of 2010, compared to 61.0% in the same period of 2009. Tongjitang's gross margin reflects higher revenue contribution from lower-margin products, as well as increased costs of raw materials related to herbal medicines, including the cost of barrenwort. Quality control costs also increased in line with a more stringent regulatory environment.

Operating loss in the second quarter of 2010 was RMB2.8 million ($0.4 million), compared to an operating profit of RMB11.7 million in the second quarter of 2009. Operating loss was mainly attributable to increased selling and marketing expenses, reflecting the Company's efforts to invest in its sales team's infrastructure and EDL sales network.

Net loss attributable to the Company was RMB4.7 million ($0.7 million), which yielded net loss per ADS of RMB0.18 ($0.03) and net loss per share(2) of RMB0.05 ($0.01).

Non-GAAP adjusted EBITDA in the second quarter of 2010 was RMB5.7 million ($0.8 million), compared to RMB27.1 million in the second quarter of 2009. Non-GAAP adjust
'/>"/>

SOURCE Tongjitang Chinese Medicines Company
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17

Related medicine technology :

1. Tongjitang Files 2009 Annual Report on Form 20-F
2. Tongjitang Chinese Medicines Company Reports First Quarter 2010 Financial Results
3. Tongjitang Chinese Medicines Acquires Guiyang Liquor Factory
4. China Medical Technologies Announces the Use of its HER-2 FISH Probe in a Cancer Targeted Therapy Research Project Sponsored by the Chinese Ministry of Health
5. China BCT Signs Exclusive Distribution Contract With Liujiang County Chinese Medicine Hospital
6. Biosites Triage Products Seized by Beijing Customs; Chinese Market Facing Shortage
7. China Sky One Medical Announces Antroquinonol Capsule Recognized as Breakthrough Drug by Chinese Ministry of Science and Technology
8. Chinese Distribution Contract Extended for an Additional 4 Years
9. Chinese State Food and Drug Administration Approves Company Facility for Producing Solid Dosage Perindopril
10. Tianyin Pharmaceutical Co., Inc. Receives Chinese SFDA Approval for Ofloxacin and Fleroxacin
11. Sinovac Obtains Fifth H1N1 Vaccine Order from Chinese Central Government
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/3/2015)... March 3, 2015  American Biosurgical, LLC ("ABI") ... cable manufacturer actively engaged in the design, development ... the world,s leading medical device companies has announced ... low volume custom medical cable manufacturer based in ... MTI brand under the name MTI Medical Cables.  ...
(Date:3/3/2015)... -- Columbia Laboratories, Inc. (Nasdaq: CBRX ) (" ... pharmaceutical company focused on pharmaceuticals for women,s health, today ... ROTH Conference, which will take place from March 8-11 ... Point, California . Management,s presentation will take place ... (12:00 p.m. Eastern Time) in the Promenade room. ...
(Date:3/3/2015)... - Sante Medical Hair Restoration is now offering the ... The ARTAS Robotic System is a state-of-the-art ... for transplantation. This latest development in minimally-invasive hair ... linear scar. "The ARTAS technology extends ... surgery." says Dr. Louis Grondin , Medical ...
Breaking Medicine Technology:American Biosurgical Acquires MTI Corporation 2No linear scar. Permanent results. 2
... Children,s Oncology Group Report Shows the Addition of ... of Death by 30% in Osteosarcoma Patients, ... IDMI ) today announced the Journal of ... 3 mifamurtide (L-MTP-PE) clinical trial,(INT-0133), entitled "Osteosarcoma: The ...
... Show Subjects Receiving,Infrequently Administered Ustekinumab Maintained Improvement from Psoriasis ... ... SAN ANTONIO, Feb. 2 One-year data from a second,double-blind, ... weeks provided sustained, clinically meaningful,improvement in the treatment of moderate ...
Cached Medicine Technology:IDM Pharma Announces Phase 3 Mifamurtide (L-MTP-PE) Study Demonstrating Improved Survival Published in the Journal of Clinical Oncology 2IDM Pharma Announces Phase 3 Mifamurtide (L-MTP-PE) Study Demonstrating Improved Survival Published in the Journal of Clinical Oncology 3IDM Pharma Announces Phase 3 Mifamurtide (L-MTP-PE) Study Demonstrating Improved Survival Published in the Journal of Clinical Oncology 4IDM Pharma Announces Phase 3 Mifamurtide (L-MTP-PE) Study Demonstrating Improved Survival Published in the Journal of Clinical Oncology 5IDM Pharma Announces Phase 3 Mifamurtide (L-MTP-PE) Study Demonstrating Improved Survival Published in the Journal of Clinical Oncology 6IDM Pharma Announces Phase 3 Mifamurtide (L-MTP-PE) Study Demonstrating Improved Survival Published in the Journal of Clinical Oncology 7Ustekinumab (CNTO 1275) Phase 3 Data Show Long-Term Improvement Of Chronic Plaque Psoriasis 2Ustekinumab (CNTO 1275) Phase 3 Data Show Long-Term Improvement Of Chronic Plaque Psoriasis 3Ustekinumab (CNTO 1275) Phase 3 Data Show Long-Term Improvement Of Chronic Plaque Psoriasis 4Ustekinumab (CNTO 1275) Phase 3 Data Show Long-Term Improvement Of Chronic Plaque Psoriasis 5
(Date:3/3/2015)... (PRWEB) March 03, 2015 Findings could ... Researchers at UC Davis have developed and characterized a ... cells, causing them to self-destruct. This novel mechanism was ... for a usually fatal type of brain cancer – ... , The article, to be published in the ...
(Date:3/3/2015)... VA (PRWEB) March 03, 2015 Today ... the Portland-based maker of bike, skate, snow, water, and ... awareness about brain injury. The partnership kicks off with ... website at http://www.nutcasehelmets.com to BIAA during the ... Month. , Each year BIAA leads the nation in ...
(Date:3/3/2015)... US Air Purifiers LLC , an Illinois based ... to announce that all Rabbit brand air purifiers are back ... west coast port strikes. This news comes just in time, ... The port strikes, which have caused significant supply ... growth by as much as 1%, have hindered the restocking ...
(Date:3/3/2015)... DePuy Pinnacle hip lawsuits (( ... the artificial hip system caused recipients to suffer ... in the federal multidistrict litigation underway in U.S. ... the most recent Master Case List issued by ... hip replacement lawsuits are now pending in the ...
(Date:3/3/2015)... (PRWEB) March 03, 2015 With a ... Georgia Health Policy Center (GHPC) has been named a ... (RWJF) to support the Bridging for Health: Improving Community ... regions, states and communities improve health and reduce disparities ... grant will support the work of the center and ...
Breaking Medicine News(10 mins):Health News:News: UC Davis Scientists Describe Novel Drug Mechanism That Fights Brain Cancer 2Health News:News: UC Davis Scientists Describe Novel Drug Mechanism That Fights Brain Cancer 3Health News:News: UC Davis Scientists Describe Novel Drug Mechanism That Fights Brain Cancer 4Health News:Brain Injury Association of America Partners with Nutcase Helmets to Raise Awareness About Brain Injury 2Health News:Rabbit Air Purifiers Back In Stock at US Air Purifiers LLC 2Health News:Rabbit Air Purifiers Back In Stock at US Air Purifiers LLC 3Health News:DePuy Pinnacle Lawsuit News: Bernstein Liebhard LLP Comments on Growing Pinnacle Hip Litigation 2Health News:DePuy Pinnacle Lawsuit News: Bernstein Liebhard LLP Comments on Growing Pinnacle Hip Litigation 3Health News:DePuy Pinnacle Lawsuit News: Bernstein Liebhard LLP Comments on Growing Pinnacle Hip Litigation 4Health News:Robert Wood Johnson Foundation Names Georgia Health Policy Center National Center for Bridging for Health Initiative 2
... HealthDay Reporter , WEDNESDAY, March 16 (HealthDay News) ... a large hospital, more patients died, a new study discovered. ... nursing shortages and cost-cutting, in that the focus should shift ... research, appearing in the March 17 issue of the ...
... Washington, DC Stephen J. Teach, MD, MPH, Medical Director ... pediatric asthma care and research at Children,s National Medical Center, ... that may advance asthma treatment and outcomes, specifically for inner-city ... the National Institutes of Health (NIH) were published and released ...
... Reporter , WEDNESDAY, March 16 (HealthDay News) -- ... city children with the respiratory condition, and almost eliminated ... When added to standard asthma treatments, Xolair (omalizumab) decreased ... control, according to the study, which is published in ...
... It is no surprise to scientists that the largest social ... their face is fundamental to our social interactions, one of ... how our brain processes facial identity. In a ... scientists used an original approach a method that "shakes" ...
... State University shows that while the number of visits to ... park operations has been significantly reduced. The reduction in funding ... $20 billion in economic impact that state parks have on ... for operations puts stress on America,s state-park systems," says Dr. ...
... , AUGUSTA, Ga. A clinical trial using an all-natural ... percent of American adults, is under way at Georgia Health ... are as dry as if you,ve closed the faucet, and ... Stephen Hsu, Molecular and Cell Biologist and co-investigator of the ...
Cached Medicine News:Health News:When Nurse Staffing Drops, Mortality Rates Rise: Study 2Health News:Stephen J. Teach, MD, MPH, part of landmark study on pediatric asthma 2Health News:Xolair Reduces Seasonal Asthma Attacks for Inner City Kids: Study 2Health News:Xolair Reduces Seasonal Asthma Attacks for Inner City Kids: Study 3Health News:Innovative technique gives vision researchers insight into how people recognize faces 2Health News:Study shows attendance at state parks grows, even as funding decreases 2Health News:Clinical trial for dry mouth funded by international oral care award 2
... low cost, low volume alternative. Whole blood is ... separated from whole blood by centrifugation in a ... the Cebus single use cartridge. The cartridge is ... activate the concentrating process. Finally, the cartridge is ...
Avitene Microfibrillar Collagen Hemostat (MCH) is used in surgical procedures as an to hemostasis when control of bleeding by ligature or conventional procedures is ineffective or impractical....
... device restores lordosis and ... less reaming of the ... Danek's Tapered Laparoscopic Instruments ... and reproducibly place the ...
3D Cranial is the most widely used surgical navigation software. Navigate with confidence and ease with displayed Zone of Accuracy and several fully automated features. 3D Cranial offers seamless int...
Medicine Products: